New drug targets high-risk leukemia before symptoms worsen
NCT ID NCT03766763
First seen Dec 11, 2025 · Last updated May 19, 2026 · Updated 28 times
Summary
This study tests whether the drug venetoclax can help people with early-stage, high-risk chronic lymphocytic leukemia (CLL). About 82 participants with specific risk factors will receive venetoclax to see if it can reduce cancer cells to very low levels in the bone marrow after 12 months. The goal is to control the disease early and prevent it from progressing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bordeaux Pessac
Pessac, 33604, France
-
CH BLOIS
Blois, 41000, France
-
CHU CAEN
Caen, 14033, France
-
Centre Henri Becquerel - Service Hématologie Clinique
Rouen, 76038, France
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
Centre Hospitalier Regional Metz Thionville
Metz, 57085, France
-
Centre leon berard
Lyon, 69008, France
-
Ch Annecy
Annecy, 74374, France
-
Ch Beziers
Béziers, 34500, France
-
Ch Cote Basque
Bayonne, 64109, France
-
Chd Le Mans
Le Mans, 72000, France
-
Chd Vendee
La Roche-sur-Yon, 85925, France
-
Chu Amiens
Amiens, 80054, France
-
Chu Angers
Angers, 49933, France
-
Chu Creteil
Créteil, 94000, France
-
Chu Estaing
Clermont-Ferrand, 63000, France
-
Chu Grenoble
Grenoble, 38043, France
-
Hopital Huriez
Lille, 59037, France
-
Hopitaljean Minjoz
Besançon, 25000, France
-
Hôpital Bretonneau - Hématologie et Thérapie Cellulaire
Tours, 37044, France
-
Hôpital Privé Sévigné
Cesson-Sévigné, 35510, France
-
Institut Bergonie
Bordeaux, 33076, France
-
Institut Paoli Calmette
Marseille, 130009, France
Conditions
Explore the condition pages connected to this study.